NRIX
NASDAQ · Biotechnology
Nurix Therapeutics Inc
$19.31
+0.45 (+2.39%)
Analyst Consensus
Strong Buy
23
Analysts
High
Coverage
Price Target
Analyst Price Target
+274.4% upside
Low Target
$45.76
Average Target
$72.29
High Target
$82.91
Current Price
$19.31
Current
$19.31
$19.31
Target
$72.29
$72.29
$45.76
$72.29 avg
$82.91
Scenario Analysis
Bear Case
$45.76
137.0%
Low target
Base Case
$72.29
+274.4%
Avg target
Bull Case
$82.91
+329.4%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$22.50
-14.2% from high
52-Week Low
$8.20
+135.6% from low
Target vs 52W High
$72.29
+221.3% vs high
Next Earnings Report
Jul 7, 2026
12d
until earnings
EPS Est: $-0.72
Earnings in 12 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 78% | $257.58 | +9.7% |
| AMGN | Hold | 44 | 50% | $190.87 | -45.0% |
| GILD | Strong Buy | 39 | 82% | $362.68 | +190.0% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -6.4% |
| REGN | Buy | 38 | 71% | $76.80 | -87.6% |
| ALNY | Strong Buy | 37 | 76% | $102.31 | -64.5% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -32.7% |
| NTRA | Strong Buy | 27 | 89% | $142.91 | -39.1% |